Martin Schuchardt

Executive Director at FIECON

Martin Schuchardt serves as the Executive Director at FIECON since May 2021, a role that encompasses CEO responsibilities while leading a team of 30 professionals across various service areas, including Market Access strategy, HEOR, and HTA submission. Martin also holds the position of Global Pricing and Market Access Director at FIECON, focusing on actionable pricing and reimbursement strategies. In addition, Martin lectures at the Biotechnology Business Institute, educating future professionals on the drug discovery process. Prior to these roles, Martin served as Global Market Access Lead at Almirall, Manager of Consulting Services at IQVIA, and held consulting roles at Batten & Company and Alcimed. Academic qualifications include a Master’s degree in Science and Business Management from Utrecht University and a Bachelor’s degree in Molecular Biology from the University of Dundee.

Location

Antioquia, Colombia

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


FIECON

FIECON was born out of the desire to make a difference in the world we live in – harnessing the power of health economics for the good of humanity. To date, we have donated over £900,000 to charitable causes. Our services: We provide services across the life cycle of a product and have worked in countries across the globe. Our key service areas comprise: • Outcomes Research • Economic Modelling • Health Technology Assessment • Value Communication • Pricing & Reimbursement Our products: We challenge the conventional and think outside the box to provide game-changing, innovative products that meet your commercial needs. Our products include: • FIECON Model Builder • FIECON Value Platform • FIECON Modelling Center powered by FIECON Model Builder Our vision is to use economics for the good of humanity. We do this by making a positive difference in the lives of our people, our clients, and our society. Our core values guide our day-to-day actions and make FIECON a great place to work: * Learn, Grow, and Flourish Together * Deliver Results and Delight Clients * Improve Lives and Build a Better World Our ultimate aspiration is to set the bar for how workplaces operate, and by 2030 we aim to achieve a number of goals: We want to test the hypothesis that you can maintain a great culture as you grow, achieving external certification through the Great Place to Work award. We want to show that we have affected millions of lives – 100M in fact – which we can quantify based on the drugs we take to market each year. We want to give back BIG both in terms of our time and donations – £10M since our founding is the first stake in the ground. We also want to demonstrate that we are meeting the highest standards for social responsibility by achieving B-Corp status. hello@fiecon.com